US-GUIDED OPTICAL TOMOGRAPHY: CORRELATION WITH CLINICOPATHOLOGIC VARIABLES IN BREAST CANCER

作者：Choi Ji Soo; Kim Min Jung^*; Youk Ji Hyun; Moon Hee Jung; Suh Hee Jung; Kim Eun Kyung

来源：Ultrasound in Medicine and Biology, 2013, 39(2): 233-240.

DOI：10.1016/j.ultrasmedbio.2012.09.014

• Breast cancer
• Ultrasound
• Optical imaging
• Diffuse optical tomography
• HER2

We tested the relat1ionships between total hemoglobin concentration (THC), as measured with ultrasound (US)-guided optical tomography, and clinicopathologic variables in invasive ductal cancers; and we evaluated the clinical significance of THC. Fifty-three patients with 65 invasive ductal carcinomas underwent US-guided biopsy and were scanned with a hand-held probe consisting of a co-registered US transducer and an NIR (near-infrared) imager. The lesion location provided by co-registered US was used to guide optical imaging. Light absorption was measured at two optical wavelengths. From this measurement, tumor angiogenesis was assessed on the basis of calculated THC. We investigated the relationships between maximum THC and clinicopathologic variables (tumor size [<= 2 cm or >2 cm], metastasis to lymph node or distant organ, histologic grade, lymphovascular invasion, status of ER, PR, HER2 and Ki-67, and triple negativity). The mean maximum THC in the breast cancers was 223.3 +/- 106.3 mu mol/L. In univariate analysis, HER2 positivity, tumor size, and Ki-67 positivity showed significant correlations with maximum THC (p < 0.05). In multivariate analysis including tumor size, and ER, PR, HER2, and Ki-67 status, HER2 positivity correlated with maximum THC significantly (p = 0.007, parameter estimate 76.44). Maximum THC correlated with HER2, Ki-67 and tumor size in this group of ductal breast carcinomas. Thus, US-guided diffuse optical tomography (US-DOT) may potentially be used to predict tumor aggressiveness in patients with invasive breast cancers. (E-mail: mines@yuhs.

• 出版日期2013-2